Journals / Turkish Journal of Chemistry / 2019 / Cilt: 43 - Sayı: 6

Step-by-step optimization of the HILIC method for simultaneous determination of abacavir, lamivudine, and zidovudine from dosage form

Pages
1597–1607
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The proposed method provided a simple procedure for the simultaneous analysis of abacavir, lamivudine,and zidovudine in their pharmaceutical preparation within approximately 2 min using the conventional HPLC system.The developed method was fully validated according to the International Council for Harmonisation guidelines from theviewpoint of selectivity, sensitivity, precision, accuracy, linearity, limit of detection, and quantification.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Combined therapy for HIV treatment shows superior efficacy in comparison to single therapy.
📊
Key Findings & Data:Furthermore,the separation and determination of the combined dosage forms hold a significant place in the pharmaceutical industry.Not only reverse phase high-performance liquid chromatography (HPLC) but also hydrophilic interaction liquid chromatography (HILIC) can be used for these purposes.
💡
Conclusion & Impact:The proposed method provided a simple procedure for the simultaneous analysis of abacavir, lamivudine,and zidovudine in their pharmaceutical preparation within approximately 2 min using the conventional HPLC system.The developed method was fully validated according to the International Council for Harmonisation guidelines from theviewpoint of selectivity, sensitivity, precision, accuracy, linearity, limit of detection, and quantification.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Combined therapy for HIV treatment shows superior efficacy in comparison to single therapy. Furthermore,the separation and determination of the combined dosage forms hold a significant place in the pharmaceutical industry.Not only reverse phase high-performance liquid chromatography (HPLC) but also hydrophilic interaction liquid chromatography (HILIC) can be used for these purposes. Contrary to conventional RP systems, HILIC may be an alternativefor the analysis of polar substances. The aim of this study was the step-by-step development of a simple, rapid, andreliable method for the simultaneous determination of antiviral compounds from their marketed formulation (Trizivir).In order to achieve this goal, various mobile phase systems, buffer types, and concentrations were prepared to provide anappropriate separation. Different types of columns were tested to find the best resolution and high efficiency for the studied compounds. The proposed method provided a simple procedure for the simultaneous analysis of abacavir, lamivudine,and zidovudine in their pharmaceutical preparation within approximately 2 min using the conventional HPLC system.The developed method was fully validated according to the International Council for Harmonisation guidelines from theviewpoint of selectivity, sensitivity, precision, accuracy, linearity, limit of detection, and quantification.

🔖

Cite This Article

GÜMÜŞTAŞ, M., USLU, B., ERKMEN, C., ÖZKAN, S. A. (2022). Step-by-step optimization of the HILIC method for simultaneous determination of abacavir, lamivudine, and zidovudine from dosage form. Turkish Journal of Chemistry, Cilt: 43 - Sayı: 6, 1597–1607. https://ajindex.com/articles/601695

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Shao HJ, Crump JA, Ramadhani HO, Uiso LO, Ole-Nguyaine S et al. Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Research and Human Retroviruses 2009; 25: 1277-1285
  2. Bernal J, Ares AM, Pol J, Wiedmer SK. Hydrophilic interaction liquid chromatography in food analysis. Journal of Chromatography A 2011; 1218: 7438-7452
  3. Abafe OA, Späth J, Fick J, Jansson S, Buckley C et al. LC-MS/MS determination of antiretroviral drugs in influents and effluents from wastewater treatment plants in KwaZulu-Natal, South Africa. Chemosphere 2018; 200: 660-670
  4. Kromdijk W, Pereira SA, Rosing H, Mulder JW, Beijnen JH et al. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2013; 919-920: 43-51
  5. Kumar DA, Rao GS, Rao JVLNS. Simultaneous determination of lamivudine, zidovudine and abacavir in tablet dosage forms by RP HPLC method. E-Journal of Chemistry 2010, 7:180-184
  6. Djurdjevic P, Laban A, Markovic S, Jelikic-Stankov M. Chemometric optimization of a RP-HPLC method for the simultaneous analysis of abacavir, lamivudine, and zidovudine in tablets. Analytical Letters 2004; 37: 2649-2667
  7. Greco G, Letzel T. Main interactions and influences of the chromatographic parameters in HILIC separations. Journal of Chromatographic Science 2013; 51: 684-693
  8. Guo Y, Gaiki S. Retention and selectivity of stationary phases for hydrophilic interaction chromatography. Journal of Chromatography A 2011; 1218: 5920-5938
  9. Dinh NP, Jonsson T, Irgum K. Probing the interaction mode in hydrophilic interaction chromatography. Journal of Chromatography A 2011; 1218: 5880-5891
  10. Karatapanis AE, Fiamegos YC, Stalikas CD. A revisit to the retention mechanism of hydrophilic interaction liquid chromatography using model organic compounds. Journal of Chromatography A 2011; 1218: 2871-2879
  11. McCalley DV. Study of the selectivity, retention mechanisms and performance of alternative silica-based stationary phases for separation of ionised solutes in hydrophilic interaction chromatography. Journal of Chromatography A 2010; 1217: 3408-3417
  12. Bieke D, Yvan VH. HILIC methods in pharmaceutical analysis. Journal of Separation Science 2010; 33: 698-715
  13. Nováková L, Svoboda P, Pavlík J. Ultra-high performance li